Jane Street Group, LLC Sage Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$30.71 - $45.71 $1.32 Million - $1.96 Million	-42,900 Reduced 47.93%	46,600 $1.54 Million
Q4 2021 Feb 15, 2022	BUY	$37.06 - $47.11 $196,418 - $249,683	5,300 Added 6.29%	89,500 $3.81 Million
Q3 2021 Nov 16, 2021	SELL	$40.26 - $57.37 $12.3 Million - $17.5 Million	-305,900 Reduced 78.42%	84,200 $3.73 Million
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $11.9 Million - $17.2 Million	216,800 Added 125.1%	390,100 $22.2 Million
Q1 2021 May 18, 2021	BUY	$70.65 - $96.76 $6.58 Million - $9.01 Million	93,100 Added 116.08%	173,300 $13 Million

Q4 2020 Feb 17, 2021	BUY	$58.41 - $89.06 $1.83 Million - $2.79 Million	31,300 Added 64.01%	80,200 $6.94 Million
Q3 2020 Nov 17, 2020	SELL	$41.13 - $62.45 $974,781 - $1.48 Million	-23,700 Reduced 32.64%	48,900 $2.99 Million
Q2 2020 Aug 17, 2020	BUY	$25.95 - $43.15 $1.56 Million - $2.59 Million	60,100 Added 480.8%	72,600 $3.02 Million
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $368,715 - $1.09 Million	-14,100 Reduced 53.01%	12,500 $359,000
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $1.41 Million - $3.64 Million	23,500 Added 758.06%	26,600 $1.92 Million
Q2 2019 Aug 15, 2019	SELL	$157.85 - $183.09 $2.49 Million - $2.89 Million	-15,800 Reduced 83.6%	3,100 $568,000
Q1 2019 May 16, 2019	BUY	$89.33 - $163.65 $1.69 Million - $3.09 Million	18,900 New	18,900 $3.01 Million

222

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.